SIM
DMAA

Sandia Investment Management’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Sandia Investment Management’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,721
Closed -$161K – 143
2025
Q3 		$161K Buy
+15,721
New +$161K 0.48% 73

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
MCS
Mercuria Capital Strategies Houston, Texas $163M AUM 258.7% 1-Year Est. Return

Sandia Investment Management's DMAA Position: Q4 2025 in Review

Sandia Investment Management sold out of Drugs Made In America Acquisition Corp (DMAA) in Q4 2025, closing a stake of 15,721 shares — an estimated $161K sold.

Sandia Investment Management first reported a position in DMAA in Q3 2025 and held it in 1 quarter. The position peaked at $161K in Q3 2025. 39 funds tracked by Wall St. Rank hold DMAA as of Q4 2025.

  • Sandia Investment Management reported no remaining Drugs Made In America Acquisition Corp position as of Q4 2025 after selling out during the quarter.
  • Sandia Investment Management sold 15,721 Drugs Made In America Acquisition Corp shares in Q4 2025, an estimated $161K.
  • Sandia Investment Management first reported a position in Drugs Made In America Acquisition Corp in Q3 2025 and held it in 1 quarter.
  • Sandia Investment Management's Drugs Made In America Acquisition Corp position peaked at $161K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.